4.5 Article

Subcellular imaging of dynamic protein interactions by bioluminescence resonance energy transfer

期刊

BIOPHYSICAL JOURNAL
卷 94, 期 3, 页码 1001-1009

出版社

BIOPHYSICAL SOC
DOI: 10.1529/biophysj.107.117275

关键词

-

向作者/读者索取更多资源

Despite the fact that numerous studies suggest the existence of receptor multiprotein complexes, visualization and monitoring of the dynamics of such protein assemblies remain a challenge. In this study, we established appropriate conditions to consider spatiotemporally resolved images of such protein assemblies using bioluminescence resonance energy transfer (BRET) in mammalian living cells. Using covalently linked Renilla luciferase and yellow fluorescent proteins, we depicted the time course of dynamic changes in the interaction between the V2-vasopressin receptor and beta-arrestin induced by a receptor agonist. The protein-protein interactions were resolved at the level of subcellular compartments (nucleus, plasma membrane, or endocytic vesicules) and in real time within tens-of-seconds to tens-of-minutes time frame. These studies provide a proof of principle as well as experimental parameters and controls required for high-resolution dynamic studies using BRET imaging in single cells.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Cell Biology

Human MC4R variants affect endocytosis, trafficking and dimerization revealing multiple cellular mechanisms involved in weight regulation

Bas Brouwers, Edson Mendes de Oliveira, Maria Marti-Solano, Fabiola B. F. Monteiro, Suli-Anne Laurin, Julia M. Keogh, Elana Henning, Rebecca Bounds, Carole A. Daly, Shane Houston, Vikram Ayinampudi, Natalia Wasiluk, David Clarke, Bianca Plouffe, Michel Bouvier, M. Madan Babu, I. Sadaf Farooqi, Jacek Mokrosinski

Summary: Research on melanocortin-4 receptor (MC4R) mutations associated with obesity reveals the importance of endocytosis, intracellular trafficking, and homodimerization in regulating MC4R function, supporting the development of novel therapies for weight loss.

CELL REPORTS (2021)

Letter Cell Biology

Cryo-EM structure of constitutively active human Frizzled 7 in complex with heterotrimeric Gs

Lu Xu, Bo Chen, Hannes Schihada, Shane C. Wright, Ainoleena Turku, Yiran Wu, Gye-Won Han, Maria Kowalski-Jahn, Pawel Kozielewicz, Carl-Fredrik Bowin, Xianjun Zhang, Chao Li, Michel Bouvier, Gunnar Schulte, Fei Xu

CELL RESEARCH (2021)

Article Biochemistry & Molecular Biology

Illuminating the complexity of GPCR pathway selectivity - advances in biosensor development

Shane C. Wright, Michel Bouvier

Summary: GPCRs continue to be a focus in drug discovery efforts due to their widespread expression and broad role in signal transduction. Despite over 800 GPCRs sharing a common architecture, unique differences govern ligand specificity and pathway selectivity. Recent biosensor development has reinforced the idea that biased signaling may become mainstream in drug discovery programs.

CURRENT OPINION IN STRUCTURAL BIOLOGY (2021)

Article Multidisciplinary Sciences

Discovery of a dual Ras and ARF6 inhibitor from a GPCR endocytosis screen

Jenna Giubilaro, Doris A. Schuetz, Tomasz M. Stepniewski, Yoon Namkung, Etienne Khoury, Monica Lara-Marquez, Shirley Campbell, Alexandre Beautrait, Sylvain Armando, Olivier Radresa, Jean Duchaine, Nathalie Lamarche-Vane, Audrey Claing, Jana Selent, Michel Bouvier, Anne Marinier, Stephane A. Laporte

Summary: A novel dual Ras and ARF6 inhibitor named Rasarfin was identified in a high-throughput screen for receptor trafficking inhibitors. Rasarfin blocks agonist-mediated internalization of GPCRs, inhibits ERK1/2 signaling, MAPK and Akt signaling, and prevents cancer cell proliferation. The unique binding modality of Rasarfin within the SOS-binding domain of Ras was revealed through in silico modeling and in vitro studies, indicating its potential for inhibiting oncogenic cellular responses.

NATURE COMMUNICATIONS (2021)

Review Pharmacology & Pharmacy

Community guidelines for GPCR ligand bias: IUPHAR review 32

Peter Kolb, Terry Kenakin, Stephen P. H. Alexander, Marcel Bermudez, Laura M. Bohn, Christian S. Breinholt, Michel Bouvier, Stephen J. Hill, Evi Kostenis, Kirill A. Martemyanov, Rick R. Neubig, H. Ongun Onaran, Sudarshan Rajagopal, Bryan L. Roth, Jana Selent, Arun K. Shukla, Martha E. Sommer, David E. Gloriam

Summary: GPCRs regulate various physiological processes and their effects depend on the pairing of a receptor and a ligand. Ligands that induce biased signalling can lead to better drug effects and fewer side effects. However, ligand bias is complex, making it necessary to develop guidelines for designing and reporting biased signalling experiments.

BRITISH JOURNAL OF PHARMACOLOGY (2022)

Article Multidisciplinary Sciences

The pocketome of G-protein-coupled receptors reveals previously untargeted allosteric sites

Janik B. Hedderich, Margherita Persechino, Katharina Becker, Franziska M. Heydenreich, Torben Gutermuth, Michel Bouvier, Moritz Buenemann, Peter Kolb

Summary: Researchers computationally describe alternative allosteric pockets in G-protein-coupled receptors, identifying nine previously untargeted sites for synthetic ligands. They further investigate the potential of modulating receptor function through ligand binding to these sites.

NATURE COMMUNICATIONS (2022)

Article Biology

Common coupling map advances GPCR-G protein selectivity

Alexander S. Hauser, Charlotte Avet, Claire Normand, Arturo Mancini, Asuka Inoue, Michel Bouvier, David E. Gloriam

Summary: Two-thirds of human hormones and one-third of clinical drugs act on membrane receptors coupled to G proteins, but there are differences in the reported G protein couplings among recent large-scale datasets. This study presents a common coupling map that uncovers novel couplings, GPCR-G protein selectivity, and the comparison of co-coupling and co-expression of G proteins with phylogenetic relationships. These findings will advance receptor research and cellular signaling, and contribute to the development of safer drugs.
Article Biology

Effector membrane translocation biosensors reveal G protein and βarrestin coupling profiles of 100 therapeutically relevant GPCRs

Charlotte Avet, Arturo Mancini, Billy Breton, Christian Le Gouill, Alexander S. Hauser, Claire Normand, Hiroyuki Kobayashi, Florence Gross, Mireille Hogue, Viktoriya Lukasheva, Stephane St-Onge, Marilyn Carrier, Madeleine Heroux, Sandra Morissette, Eric B. Fauman, Jean-Philippe Fortin, Stephan Schann, Xavier Leroy, David E. Gloriam, Michel Bouvier

Summary: This study presents a set of BRET sensors to monitor the activation of G protein subtypes without modifying the receptors or G proteins. Profiling 100 therapeutically relevant human GPCRs resulted in pathway-specific concentration-response curves, revealing a diversity of coupling profiles.
Article Genetics & Heredity

Measuring S-Phase Duration from Asynchronous Cells Using Dual EdU-BrdU Pulse-Chase Labeling Flow Cytometry

Marta Bialic, Baraah Al Ahmad Nachar, Maria Kozlak, Vincent Coulon, Etienne Schwob

Summary: This article describes a simple and robust method to measure the duration of the S phase in cell cultures. It utilizes a dual EdU-BrdU pulse-labeling regimen with incremental thymidine chases and quantification by flow cytometry. The method does not require cell synchronization or genome engineering and can be used for various types of cells.
Article Pharmacology & Pharmacy

Michaelis-Menten Quantification of Ligand Signaling Bias Applied to the Promiscuous Vasopressin V2 Receptor

Franziska Marie Heydenreich, Bianca Plouffe, Aurelien Rizk, Dalibor Milic, Joris Zhou, Billy Breton, Christian Le Gouill, Asuka Inoue, Michel Bouvier, Dmitry B. Veprintsev

Summary: By modeling G protein activation as a Michaelis-Menten reaction, we have developed a novel method for quantifying signaling bias. V2R activates, or at least engages, G proteins from all G protein subfamilies, including Gi2, Gz, Gq, G12, and G13. Their relative activation may explain its Gs-independent signaling.

MOLECULAR PHARMACOLOGY (2022)

Article Biochemistry & Molecular Biology

Gαs is dispensable for (3-arrestin coupling but dictates GRK selectivity and is predominant for gene expression regulation by (32-adrenergic receptor

Valeria Burghi, Justine S. Paradis, Adam Officer, Sendi Rafael Adame-Garcia, Xingyu Wu, Edda S. F. Matthees, Benjamin Barsi-Rhyne, Dana J. Ramms, Lauren Clubb, Monica Acosta, Pablo Tamayo, Michel Bouvier, Asuka Inoue, Mark von Zastrow, Carsten Hoffmann, J. Silvio Gutkind

Summary: This study focuses on the role of beta-arrestins in G protein-coupled receptor (GPCR) signaling. It is found that while G proteins are essential for GPCR signaling, beta-arrestins play a more prominent role in signal compartmentalization and modulation of gene expression.

JOURNAL OF BIOLOGICAL CHEMISTRY (2023)

Article Multidisciplinary Sciences

GLP-1R signaling neighborhoods associate with the susceptibility to adverse drug reactions of incretin mimetics

Shane C. Wright, Aikaterini Motso, Stefania Koutsilieri, Christian M. Beusch, Pierre Sabatier, Alessandro Berghella, Elodie Blondel-Tepaz, Kimberley Mangenot, Ioannis Pittarokoilis, Despoina-Christina Sismanoglou, Christian Le Gouill, Jesper V. Olsen, Roman A. Zubarev, Nevin A. Lambert, Alexander S. Hauser, Michel Bouvier, Volker M. Lauschke

Summary: This study investigates the subcellular location of GLP-1R signaling events and reveals associations between signaling profiles and adverse drug reactions, providing important insights for rational drug design and improving the therapeutic potential of GLP-1R agonists.

NATURE COMMUNICATIONS (2023)

Article Chemistry, Medicinal

Comprehensive Signaling Profiles Reveal Unsuspected Functional Selectivity of δ-Opioid Receptor Agonists and Allow the Identification of Ligands with the Greatest Potential for Inducing Cyclase Superactivation

Ahmed Mansour, Karim Nagi, Paul Dallaire, Viktoriya Lukasheva, Christian Le Gouill, Michel Bouvier, Graciela Pineyro

Summary: Long-term exposure to opioid receptor agonists leads to adaptations in the AC pathway, resulting in enhanced cAMP production and impacting chronic pain management. Different DOPr agonists exhibit distinct signaling profiles, with functional selectivity influenced by Ca2+ mobilization.

ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2021)

Article Chemistry, Multidisciplinary

Mechanistic insights into dopaminergic and serotonergic neurotransmission - concerted interactions with helices 5 and 6 drive the functional outcome

Tomasz Maciej Stepniewski, Arturo Mancini, Richard Agren, Mariona Torrens-Fontanals, Meriem Semache, Michel Bouvier, Kristoffer Sahlholm, Billy Breton, Jana Selent

Summary: This research combines various techniques to study the actions of dopamine on the dopaminergic D-2 receptor, revealing how neurotransmitter binding leads to the activation of different effectors. Experiments show that key residues in TM5 and TM6 are involved in coupling with effectors, while sequence variation at position 6.55 can fine-tune beta-arrestin recruitment and regulate receptor signaling and internalization of neurotransmitter receptors.

CHEMICAL SCIENCE (2021)

Article Chemistry, Medicinal

Proadrenomedullin N-Terminal 20 Peptides (PAMPs) Are Agonists of the Chemokine Scavenger Receptor ACKR3/CXCR7

Max Meyrath, Christie B. Palmer, Nathan Reynders, Alain Vanderplasschen, Markus Ollert, Michel Bouvier, Martyna Szpakowska, Andy Chevigne

Summary: The study compared the activation of ACKR3 by ADM and PAMP, finding that PAMP had a stronger potency towards ACKR3 than ADM. Importantly, PAMP-12 was efficiently internalized by ACKR3 without inducing G protein or ERK signaling in vitro.

ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2021)

暂无数据